Tue, 4th March 2025

9:50 am

Sale confirmation of a Director

Mr. Md. Mohiuddin Ahmed, a Director of the company, has completed sale of his entire holding of 100,000 shares of the through Dhaka Stock Exchange PLC. as per declaration disseminated on 03.02.2025.

Wed, 26th February 2025

10:31 am

Category Change

The Company will be placed in 'A' category from existing 'B' category with effect from February 27, 2025 as the Company has reported disbursement of 10% Cash Dividend for the year ended June 30, 2024.

Wed, 26th February 2025

10:31 am

Dividend Disbursement

The company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.

Thu, 20th February 2025

7:49 am

Auditor's report regarding status of IPO Proceeds utilization

JMI Hospital Requisite Mfg. Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the quarter ended December 31, 2024. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/JMIHOSPITAL_2024.pdf

Mon, 3rd February 2025

7:04 am

Sale Declaration of a Director

Mr. Md. Mohiuddin Ahmed, a Director of the company, has expressed intention to sell his entire holding of 100,000 shares of the company at prevailing market price (in the Public Market) through Dhaka Stock Exchange PLC. within next 30 working days.

Thu, 30th January 2025

4:05 am

Q2 Financials

(Cont. News of JHRML): Reasons for deviation: EPS has decreased because of the imported raw material purchases are at high prices compared with sales in the local market. NOCFPS has decreased because of an increase in accounts receivable and an increase in advance deposit and prepayment in the subsidiary company. (end)

Thu, 30th January 2025

4:05 am

Q2 Financials

(Q2 Un-audited): Consolidated EPS was Tk. 0.51 for October-December 2024 as against Tk. 0.63 for October-December 2023; Consolidated EPS was Tk. 1.06 for July-December 2024 as against Tk. 1.17 for July-December 2023. Consolidated NOCFPS was Tk. 0.36 for July-December 2024 as against Tk. 1.07 for July-December 2023. Consolidated NAV per share was Tk. 35.01 as on December 31, 2024 and Tk. 33.95 as on June 30, 2024. (cont.)

Sun, 19th January 2025

4:29 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2025 at 5:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.

Mon, 30th December 2024

7:45 am

Credit Rating Result

Alpha Credit Rating PLC (Alpha Rating) has assigned the Surveillance rating of the Company as "A+" in the long term and "ST-2" in the short term along with Stable outlook based on the audited financial statements as on June 30, 2024 and relevant qualitative information till December 29, 2024.

Tue, 26th November 2024

7:10 am

Resumption after Record Date

Trading of the shares of the company will resume on 27.11.2024.

Mon, 25th November 2024

7:30 am

Suspension for Record Date

Trading of the shares of the company will remain suspended on record date i.e., 26.11.2024.

Thu, 21st November 2024

6:44 am

Spot News

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 24.11.2024 to 25.11.2024 and trading of the shares will remain suspended on record date i.e., 26.11.2024.

Wed, 13th November 2024

4:04 am

Q1 Financials

(Q1 Un-audited): Consolidated EPS was Tk. 0.55 for July-September 2024 as against Tk. 0.54 (Solo) for July-September 2023; Consolidated NOCFPS was Tk. 0.14 for July-September 2024 as against Tk. 0.12 (Solo) for July-September 2023. Consolidated NAV per share was Tk. 34.50 as on September 30, 2024 and Tk. 33.95 as on June 30, 2024.

Thu, 7th November 2024

6:39 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2024 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.

Thu, 24th October 2024

4:04 am

Price Limit Open

There will be no price limit on the trading of the shares of the Company today (24.10.2024) following its corporate declaration.

Thu, 24th October 2024

4:04 am

Dividend Declaration and investment in a Subsidiary

(Cont. news of JHRML): Record Date: 26.11.2024. The Company has also reported consolidated EPS of Tk. 2.34, consolidated NAV per share of Tk. 33.95 and consolidated NOCFPS of Tk. 2.36 for the year ended June 30, 2024 as against Tk. 2.41 (solo), Tk. 32.12 (solo) and Tk. 3.70 (solo) respectively for the year ended June 30, 2023. The Board of Directors has also approved further investment of Tk. 8.00 crore in its subsidiary, JMI Specialized Hospital Limited. (end)

Thu, 24th October 2024

4:04 am

Dividend Declaration and investment in a Subsidiary

The Board of Directors has recommended 10% Cash Dividend to general shareholders other than sponsors and directors for the year ended June 30, 2024. Out of the total shares of the company, the sponsors and directors hold 40,464,500 shares and General shareholders hold 84,829,620 shares. The cash dividend payable to the general shareholders is Tk. 84,829,620.00. Date of AGM: 23.01.2025, Time: 11:00 AM, Venue: The AGM venue details will be conveyed through AGM notice. (cont.)

Mon, 14th October 2024

7:14 am

Board Meeting schedule under LR 19(1)

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 23, 2024 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.

Tue, 30th April 2024

4:04 am

Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.56 for January-March 2024 as against Tk. 0.54 for January-March 2023; EPS was Tk. 1.73 for July 2023-March 2024 as against Tk. 1.59 for July 2022-March 2023. NOCFPS was Tk. 1.82 for July 2023-March 2024 as against Tk. 2.16 for July 2022-March 2023. NAV per share was Tk. 33.35 as on March 31, 2024 and Tk. 32.12 as on June 30, 2023.

Mon, 22nd April 2024

6:59 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2024 at 03:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2024.

Thu, 21st March 2024

5:54 am

Dividend Disbursement

The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2023 to the respective shareholders.

Wed, 31st January 2024

4:02 am

Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.63 for October-December 2023 as against Tk. 0.52 for October-December 2022; EPS was Tk. 1.17 for July-December 2023 as against Tk. 1.05 for July-December 2022. NOCFPS was Tk. 1.07 for July-December 2023 as against Tk. 0.98 for July-December 2022. NAV per share was Tk. 33.28 as on December 31, 2023 and Tk. 32.12 as on June 30, 2023.

Wed, 24th January 2024

4:04 am

Agreement of JSHL, a subsidiary of JHRML, with AHLL

(Continuation news of JHRML): 7th floor, Ameerpet Hyderabad, India. Whereas, both the parties have mutually agreed that JSHL will use Apollo Health and Lifestyle Limited's trademark, logo and name "Apollo Clinic" as well as their technical knowledge, know-how and management expertise for establishing and operating a Clinic in Bangladesh named Apollo Clinic, which has been approved by the Board of Directors of JMI Hospital Requisite Manufacturing Limited in its Meeting held on 23 January 2024. (end)

Wed, 24th January 2024

4:04 am

Agreement of JSHL, a subsidiary of JHRML, with AHLL

The company has informed that they formed a subsidiary company on August 06, 2023 in the name of JMI Specialized Hospital Limited, a healthcare service providing company, having authorized capital of BDT 50.00 Crore and paid-up capital of BDT 20.00 Crore wherein JHRML holds 65% shares. JMI Specialized Hospital Limited (JSHL) signed a License Agreement on 23 January 2024 with Apollo Health and Lifestyle Limited (AHLL), Registered office at 7-1-617/A, 615 & 616, Imperial Tower, (cont.)

Tue, 23rd January 2024

7:54 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2024 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2023.

Mon, 22nd January 2024

10:31 am

Category Change

The Company will be placed in 'B' category from existing 'A' category with effect from January 23, 2024 as the Company has approved 5% Cash Dividend for the year ended June 30, 2023.

Mon, 22nd January 2024

6:49 am

Shareholders' approval for the revised use of IPO proceeds

Refer to their earlier news disseminated by DSE on 19.10.2023, the company has further informed that the shareholders of the company have approved the revised use of IPO proceeds in the 15th AGM of the company held on January 22, 2024.

Tue, 26th December 2023

5:40 am

Credit Rating Result (Revised)

Alpha Credit Rating Limited has assigned surveillance rating of the Company as "A+" in the long term and "ST-2" in the short term along with Stable outlook based on audited financial statements as on June 30, 2023 and relevant qualitative information till December 25, 2023.

Tue, 26th December 2023

4:15 am

Credit Rating Result

Alpha Credit Rating Limited has assigned surveillance rating of the Company as "A+" in the long term and "ST-2" in the short term along with Stable outlook based on audited financial statements as on June 30, 2023 and relevant qualitative information till December 23, 2023.

Sun, 26th November 2023

7:04 am

Resumption after Record Date

Trading of the shares of the company will resume on 27.11.2023.

Thu, 23rd November 2023

6:20 am

Suspension for Record date

Trading of the shares of the company will remain suspended on record date i.e., 26.11.2023.

Tue, 21st November 2023

6:15 am

Spot News

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 22.11.2023 to 23.11.2023 and trading of the shares will remain suspended on record date i.e., 26.11.2023.

Thu, 9th November 2023

4:05 am

Q1 Financials

(Q1 Un-audited): EPS was Tk. 0.54 for July-September 2023 as against Tk. 0.53 for July-September 2022; NOCFPS was Tk. 0.12 for July-September 2023 as against Tk. 0.91 for July-September 2022. NAV per share was Tk. 32.66 as on September 30, 2023 and Tk. 32.12 as on June 30, 2023.

Thu, 2nd November 2023

7:20 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 08, 2023 at 2:45 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2023.

Thu, 26th October 2023

8:30 am

Emphasis of Matter

The auditor of the company has given the "Emphasis of Matter" paragraph in the Auditor's Report of the company for the year ended June 30, 2023. To view the details, please visit: https://www.dsebd.org/assets/pdf/EmpJMI_HOSPITAL_REQUISITE_MANUFACTURING_LTD30June2023.pdf

Thu, 19th October 2023

4:05 am

Price Limit Open

There will be no price limit on the trading of the shares of the Company today (19.10.2023) following its corporate declaration. However, the floor price shall be applicable accordingly.

Thu, 19th October 2023

4:05 am

Dividend Declaration and Revision of the use of IPO Proceeds

(Continuation news of JHRML): The Board of Directors of the company has also approved and recommended to revise the use of IPO proceeds, due to Covid-19, dollar crisis, Russia-Ukraine war, interruption in opening L/C and adding new component of machinery as well as new machinery lines subject to the approval of shareholders in the upcoming 15th AGM and Bangladesh Securities and Exchange Commission. (end)

Thu, 19th October 2023

4:05 am

Dividend Declaration and Revision of the use of IPO Proceeds

The Board of Directors has recommended 5% Cash Dividend for the year ended June 30, 2023. Date of AGM: 22.01.2024, Time: 11:00 AM, Venue: Digital Platform. Record Date: 26.11.2023. The Company has also reported EPS of Tk. 2.41, NAV per share of Tk. 32.12 and NOCFPS of Tk. 3.70 for the year ended June 30, 2023 as against Tk. 3.25, Tk. 38.84 and Tk. 4.26 respectively for the year ended June 30, 2022. (cont.)

Tue, 10th October 2023

6:10 am

Board Meeting schedule under LR 19(1)

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 18, 2023 at 5:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2023.

Mon, 31st July 2023

4:05 am

Board decision regarding formation of a new subsidiary company

The company has informed that the Board of Directors of the Company has decided to form a new subsidiary company under the title of "JMI Specialized Hospital Limited" having its authorized capital of BDT 50 (Fifty) Crore and a paid up capital of BDT 20 (Twenty) Crore wherein the Company shall hold 65% shares subject to the approval of concerned authorities.

Tue, 2nd May 2023

4:05 am

Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.54 for January-March 2023 as against Tk. 1.60 for January-March 2022; EPS was Tk. 1.59 for July 2022-March 2023 as against Tk. 2.89 for July 2021-March 2022. NOCFPS was Tk. 2.16 for July 2022-March 2023 as against Tk. 2.38 for July 2021-March 2022. NAV per share was Tk. 31.29 as on March 31, 2023 and Tk. 38.84 as on June 30, 2022.

Sun, 16th April 2023

4:04 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2023 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2023.

Mon, 20th February 2023

10:32 am

Category Change

The Company will be placed in 'A' category from existing 'N' category with effect from February 22, 2023 as the Company has reported disbursement of 12.50% cash dividend for the year ended June 30, 2022.

Mon, 20th February 2023

8:20 am

Dividend Disbursement

The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2022 to the respective shareholders.

Tue, 31st January 2023

4:05 am

Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.52 for October-December 2022 as against Tk. 0.66 for October-December 2021; EPS was Tk. 1.05 for July-December 2022 as against Tk. 1.29 for July-December 2021. NOCFPS was Tk. 0.98 for July-December 2022 as against Tk. 1.93 for July-December 2021. NAV per share was Tk. 32.00 as on December 31, 2022 and Tk. 38.84 as on June 30, 2022.

Mon, 23rd January 2023

10:31 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2023 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2022.

Tue, 27th December 2022

7:40 am

Credit Rating Result

Alpha Credit Rating Limited (Alpha Rating) has assigned the surveillance rating of the Company as "A+" in the long term and "ST-2" in the short term along with a stable outlook based on audited financial statement of the company for the year ended June 30, 2022 and relevant qualitative information till December 26, 2022.

Sun, 18th December 2022

8:20 am

Special resolution regarding related party transaction

The company has informed that they have decided to place an agenda to approve related party transaction for the year ended June 30, 2022, among others, as special business for approval of shareholders in 14th AGM scheduled to be held on January 12, 2023 at 11:00 AM. Special resolution: Resolved that the related party transactions of the sister concern of the Company are hereby approved by the board of directors, that the matter be placed before the upcoming 14th AGM for approval by the shareholders.

Wed, 7th December 2022

5:54 am

Regarding Office Address

The Company has informed that the construction works are ongoing in their Registered office address at Holdings # 72/C, Progoti Shoroni, Middle Badda, Dhaka-1212 and they mentioned Corporate office and mailing address at Unique Heights (Level -11), 117 Kazi Nazrul Islam Avenue, Ramna, Dhaka- 1217 for easy communication.

Wed, 30th November 2022

8:10 am

Resumption after record date

Trading of the shares of the Company will resume on 01.12.2022 after record date.

Tue, 29th November 2022

7:44 am

Suspension for Record date

Trading of the shares of the Company will remain suspended on record date i.e., 30.11.2022.

Sun, 27th November 2022

6:44 am

Spot News

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 28.11.2022 to 29.11.2022. Trading of the shares of the Company will remain suspended on record date i.e., 30.11.2022.

Wed, 23rd November 2022

4:00 am

Sector Change of the Company

Dhaka Stock Exchange Limited (DSE) has approved the proposed sector change of the Company. Accordingly, the business sector of JMI Hospital Requisite Manufacturing Limited will be changed to "Pharmaceuticals & Chemicals " instead of "Miscellaneous" sector with effect from November 23, 2022. Other things (except sector) will remain unchanged.

Sun, 13th November 2022

3:29 am

Q1 Financials

(Q1 Un-audited): EPS was Tk. 0.53 for July-September 2022 as against Tk. 0.64 for July-September 2021; NOCFPS was Tk. 0.91 for July-September 2022 as against Tk. 1.46 for July-September 2021. NAV per share was Tk. 31.49 as on September 30, 2022 and Tk. 32.13 as on September 30, 2021.

Wed, 2nd November 2022

6:20 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2022 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2022.

Wed, 26th October 2022

4:50 am

Update of Information

The Company has requested the Shareholders to check and update their BO IDs, Bank accounts, e-mail IDs, 12 digit E-TIN and other necessary information before Record Date i.e. November 30, 2022.

Wed, 26th October 2022

3:30 am

Price Limit Open

There will be no price limit on the trading of the shares of the Company today (26.10.2022) following its corporate declaration.

Wed, 26th October 2022

3:30 am

Dividend Declaration and Revision of the use of IPO Proceeds

(Continuation news of JHRML): The Board of Directors of the company has also approved and recommended to revise the use of IPO proceeds, due to Covid-19, Changes of exchange rate, Russia-Ukraine war and adding new component of machinery as well as new machinery line subject to the approval of shareholders in the upcoming 14th AGM and Bangladesh Securities & Exchange Commission. (end)

Wed, 26th October 2022

3:30 am

Dividend Declaration and Revision of the use of IPO Proceeds

The Board of Directors has recommended 12.50% cash dividend for the year ended June 30, 2022. Date of AGM: 12.01.2023, Time: 11:00 AM, Venue: Digital Platform. Record Date: 30.11.2022. The Company has also reported EPS of Tk. 3.25, NAV per share of Tk. 38.84 and NOCFPS of Tk. 4.26 for the year ended June 30, 2022 as against Tk. 2.50, Tk. 31.49 and Tk. 3.04 respectively for the same period of the previous year. (cont.)

Thu, 13th October 2022

6:05 am

Board Meeting schedule under LR 19(1)

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 25, 2022 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.

Tue, 13th September 2022

10:02 am

Query Response

In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.

Wed, 27th April 2022

4:34 am

Decision to purchase land

The Company has informed that the Board of Directors has approved a cost of BDT. 4,25,00,000 in connection to acquire of 34 decimal land including its registration cost and development of the same at adjacent to the existing project site, Vitikandi, Gazaria, Munshigonj, in the name of JMI Hospital Requisite Manufacturing Limited for its expansion and payment for the same will be made from IPO proceeds.

Wed, 27th April 2022

4:24 am

Q3 Financials

(Q3 Un-audited): EPS was Tk. 1.60 for January-March 2022 as against Tk. 0.49 for January-March 2021; EPS was Tk. 2.89 for July 2021-March 2022 as against Tk. 1.70 for July 2020-March 2021. NOCFPS was Tk. 2.38 for July 2021-March 2022 as against Tk. 2.61 for July 2020-March 2021. NAV per share was Tk. 30.69 as on March 31, 2022 and Tk. 31.49 as on June 30, 2021.

Tue, 19th April 2022

10:16 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 26, 2022 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2022.

Thu, 31st March 2022

4:05 am

Q2 Financials

(Continuation news of JHRML): Pre-IPO weighted average paid-up number of shares for 3 (three) months (October-December 2021) and 6 (six) months (July-December 2021) period ended 31 December 2021 was 90,000,000 which was same for the same period of the previous year and Post-IPO paid-up number of shares would be 125,294,120. (end)

Thu, 31st March 2022

4:05 am

Q2 Financials

(Continuation news of JHRML): However, Post-IPO EPS would be BDT 0.93 for 6 (six) months (July-December 2021) period ended 31 December 2021. Pre-IPO Net Asset Value (NAV) per share (considering Pre-IPO paid up shares) would be BDT 32.78 as on 31 December 2021 and the same would be BDT 29.54 (considering Post-IPO paid up shares). (cont. 3)

Thu, 31st March 2022

4:05 am

Q2 Financials

(Continuation news of JHRML): However, Post-IPO basic EPS for the 3 (three) months (October-December 2021) period ended 31 December 2021 would be BDT 0.48. Moreover, profit after tax is BDT 116.21 million and basic EPS of BDT 1.29 for the 6 (six) months (July-December 2021) period ended 31 December 2021 against profit after tax of BDT 109.21 million and basic EPS of BDT 1.21 for the same period of the previous year. (cont. 2)

Thu, 31st March 2022

4:05 am

Q2 Financials

(Q2 Un-audited): As per un-audited Q2 financial statements, profit after tax is BDT 59.77 million and basic EPS of BDT 0.66 for the 3 (three) months (October-December 2021) period ended 31 December 2021 against profit after tax of BDT 54.60 million and basic EPS of BDT 0.61 for the same period of the previous year. (cont. 1)

Thu, 31st March 2022

4:05 am

Prohibition on providing loan facilities to purchase securities

DSE NEWS: The Stock Brokers, Merchant Bankers and Portfolio Managers are requested to abstain from providing loan facilities to purchase securities of JMI Hospital Requisite Manufacturing Limited in between 1st to 30th trading days starting from today i.e. March 31, 2022 as per BSEC Directive No. BSEC/CMRRCD/2009-193/32 dated December 26, 2021.

Thu, 31st March 2022

4:05 am

Trading of New Security

Trading of the shares of JMI Hospital Requisite Manufacturing Limited will commence at DSE from today i.e. March 31, 2022 under 'N' category. DSE Trading Code for JMI Hospital Requisite Manufacturing Limited is "JHRML" and DSE Company Code is 99644.